{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:59:50Z","timestamp":1777478390692,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T00:00:00Z","timestamp":1427155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s12012-015-9318-y","type":"journal-article","created":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T10:19:59Z","timestamp":1427105999000},"page":"111-121","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Cardiac Fas-Dependent and Mitochondria-Dependent Apoptotic Pathways in a Transgenic Mouse Model of Huntington\u2019s Disease"],"prefix":"10.1007","volume":"16","author":[{"given":"Bor-Tsang","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Chang","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Yi","family":"Tasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Hua","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woei-Cherng","family":"Shyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Lan","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Yang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-Da","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,3,24]]},"reference":[{"key":"9318_CR1","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1212\/WNL.38.5.769","volume":"38","author":"DJ Lanska","year":"1988","unstructured":"Lanska, D. J., Lavine, L., Lanska, M. J., & Schoenberg, B. S. (1988). Huntington\u2019s disease mortality in the United States. Neurology, 38, 769\u2013772.","journal-title":"Neurology"},{"key":"9318_CR2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"MF Perutz","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993). A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell 72:971\u2013983.","journal-title":"Cell"},{"key":"9318_CR3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0968-0004(98)01350-4","volume":"24","author":"MF Perutz","year":"1999","unstructured":"Perutz, M. F. (1999). Glutamine repeats and neurodegenerative diseases: Molecular aspects. Trends in Biochemical Sciences, 24, 58\u201363.","journal-title":"Trends in Biochemical Sciences"},{"key":"9318_CR4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5694\/j.1326-5377.1982.tb132224.x","volume":"1","author":"E Chiu","year":"1982","unstructured":"Chiu, E., & Alexander, L. (1982). Causes of death in Huntington\u2019s disease. Medical Journal of Australia, 1, 153.","journal-title":"Medical Journal of Australia"},{"key":"9318_CR5","doi-asserted-by":"crossref","first-page":"RRN1266","DOI":"10.1371\/currents.RRN1266","volume":"3","author":"AM Schroeder","year":"2011","unstructured":"Schroeder, A. M., Loh, D. H., Jordan, M. C., Roos, K. P., & Colwell, C. S. (2011). Baroreceptor reflex dysfunction in the BACHD mouse model of Huntington\u2019s disease. PLoS Currents, 3, RRN1266.","journal-title":"PLoS Currents"},{"key":"9318_CR6","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1113\/jphysiol.2012.238113","volume":"590","author":"H Kiriazis","year":"2012","unstructured":"Kiriazis, H., Jennings, N. L., Davern, P., Lambert, G., Su, Y., Pang, T., et al. (2012). Neurocardiac dysregulation and neurogenic arrhythmias in a transgenic mouse model of Huntington\u2019s disease. The Journal of Physiology, 590, 5845\u20135860.","journal-title":"The Journal of Physiology"},{"key":"9318_CR7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/hmg\/8.5.813","volume":"8","author":"K Sathasivam","year":"1999","unstructured":"Sathasivam, K., Hobbs, C., Turmaine, M., Mangiarini, L., Mahal, A., Bertaux, F., et al. (1999). Formation of polyglutamine inclusions in non-CNS tissue. Human Molecular Genetics, 8, 813\u2013822.","journal-title":"Human Molecular Genetics"},{"key":"9318_CR8","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/CIRCULATIONAHA.107.750232","volume":"117","author":"JS Pattison","year":"2008","unstructured":"Pattison, J. S., Sanbe, A., Maloyan, A., Osinska, H., Klevitsky, R., & Robbins, J. (2008). Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure. Circulation, 117, 2743\u20132751.","journal-title":"Circulation"},{"key":"9318_CR9","doi-asserted-by":"crossref","first-page":"821","DOI":"10.4161\/auto.6502","volume":"4","author":"JS Pattison","year":"2008","unstructured":"Pattison, J. S., & Robbins, J. (2008). Protein misfolding and cardiac disease: Establishing cause and effect. Autophagy, 4, 821\u2013823.","journal-title":"Autophagy"},{"key":"9318_CR10","doi-asserted-by":"crossref","first-page":"e1004024","DOI":"10.1371\/journal.pgen.1004024","volume":"9","author":"GC Melkani","year":"2013","unstructured":"Melkani, G. C., Trujillo, A. S., Ramos, R., Bodmer, R., Bernstein, S. I., & Ocorr, K. (2013). Huntington\u2019s disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart. PLoS Genetics, 9, e1004024.","journal-title":"PLoS Genetics"},{"key":"9318_CR11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/JHD-2012-120004","volume":"1","author":"NI Wood","year":"2012","unstructured":"Wood, N. I., Sawiak, S. J., Buonincontri, G., Niu, Y., Kane, A. D., Carpenter, T. A., et al. (2012). Direct evidence of progressive cardiac dysfunction in a transgenic mouse model of Huntington\u2019s disease. Journal of Huntington\u2019s Disease, 1, 57\u201364.","journal-title":"Journal of Huntington\u2019s Disease"},{"key":"9318_CR12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/JHD-130083","volume":"3","author":"G Buonincontri","year":"2014","unstructured":"Buonincontri, G., Wood, N. I., Puttick, S. G., Ward, A. O., Carpenter, T. A., Sawiak, S. J., & Morton, A. J. (2014). Right ventricular dysfunction in the R6\/2 transgenic mouse model of Huntington\u2019s disease is unmasked by dobutamine. Journal of Huntington\u2019s Disease, 3, 25\u201332.","journal-title":"Journal of Huntington\u2019s Disease"},{"key":"9318_CR13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.nbd.2006.09.016","volume":"25","author":"MJ Mihm","year":"2007","unstructured":"Mihm, M. J., Amann, D. M., Schanbacher, B. L., Altschuld, R. A., Bauer, J. A., & Hoyt, K. R. (2007). Cardiac dysfunction in the R6\/2 mouse model of Huntington\u2019s disease. Neurobiology of Disease, 25, 297\u2013308.","journal-title":"Neurobiology of Disease"},{"key":"9318_CR14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1471-4892(01)00032-7","volume":"1","author":"NH Bishopric","year":"2001","unstructured":"Bishopric, N. H., Andreka, P., Slepak, T., & Webster, K. A. (2001). Molecular mechanisms of apoptosis in the cardiac myocyte. Current Opinion in Pharmacology, 1, 141\u2013150.","journal-title":"Current Opinion in Pharmacology"},{"key":"9318_CR15","doi-asserted-by":"crossref","first-page":"12825","DOI":"10.1073\/pnas.202474099","volume":"99","author":"LA Kubasiak","year":"2002","unstructured":"Kubasiak, L. A., Hernandez, O. M., Bishopric, N. H., & Webster, K. A. (2002). Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proceedings of the National Academy of Sciences of the United States of America, 99, 12825\u201312830.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9318_CR16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1042\/bss0660017","volume":"66","author":"GC Brown","year":"1999","unstructured":"Brown, G. C., & Borutaite, V. (1999). Nitric oxide, cytochrome c and mitochondria. Biochemical Society Symposia, 66, 17\u201325.","journal-title":"Biochemical Society Symposia"},{"key":"9318_CR17","doi-asserted-by":"crossref","first-page":"36217","DOI":"10.1074\/jbc.M006620200","volume":"275","author":"S Bang","year":"2000","unstructured":"Bang, S., Jeong, E. J., Kim, I. K., Jung, Y. K., & Kim, K. S. (2000). Fas-and tumor necrosis factor-mediated apoptosis uses the same binding surface of FADD to trigger signal transduction. A typical model for convergent signal transduction. Journal of Biological Chemistry, 275, 36217\u201336222.","journal-title":"Journal of Biological Chemistry"},{"key":"9318_CR18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1044-5323(03)00031-9","volume":"15","author":"BC Barnhart","year":"2003","unstructured":"Barnhart, B. C., Alappat, E. C., & Peter, M. E. (2003). The CD95 type I\/type II model. Seminars in Immunology, 15, 185\u2013193.","journal-title":"Seminars in Immunology"},{"key":"9318_CR19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00262-004-0604-y","volume":"54","author":"I Jeremias","year":"2005","unstructured":"Jeremias, I., Stahnke, K., & Debatin, K. M. (2005). CD95\/Apo-1\/Fas: Independent cell death induced by doxorubicin in normal cultured cardiomyocytes. Cancer Immunology, Immunotherapy, 54, 655\u2013662.","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"9318_CR20","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0083-6729(04)67023-3","volume":"67","author":"BB Aggarwal","year":"2004","unstructured":"Aggarwal, B. B., Bhardwaj, U., & Takada, Y. (2004). Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors. Vitamins and Hormones, 67, 453\u2013483.","journal-title":"Vitamins and Hormones"},{"key":"9318_CR21","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1074\/jbc.274.2.1156","volume":"274","author":"A Gross","year":"1999","unstructured":"Gross, A., Yin, X. M., Wang, K., Wei, M. C., Jockel, J., Milliman, C., et al. (1999). Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1\/Fas death. Journal of Biological Chemistry, 274, 1156\u20131163.","journal-title":"Journal of Biological Chemistry"},{"key":"9318_CR22","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/hmg\/ddq322","volume":"19","author":"MC Chiang","year":"2010","unstructured":"Chiang, M. C., Chen, C. M., Lee, M. R., Chen, H. W., Chen, H. M., Wu, Y. S., et al. (2010). Modulation of energy deficiency in Huntington\u2019s disease via activation of the peroxisome proliferator-activated receptor gamma. Human Molecular Genetics, 19, 4043\u20134058.","journal-title":"Human Molecular Genetics"},{"key":"9318_CR23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1471-4159.2005.03029.x","volume":"93","author":"SY Chou","year":"2005","unstructured":"Chou, S. Y., Lee, Y. C., Chen, H. M., Chiang, M. C., Lai, H. L., Chang, H. H., et al. (2005). CGS21680 attenuates symptoms of Huntington\u2019s disease in a transgenic mouse model. Journal of Neurochemistry, 93, 310\u2013320.","journal-title":"Journal of Neurochemistry"},{"key":"9318_CR24","doi-asserted-by":"crossref","first-page":"e1004550","DOI":"10.1371\/journal.pgen.1004550","volume":"10","author":"M Mielcarek","year":"2014","unstructured":"Mielcarek, M., Inuabasi, L., Bondulich, M. K., Muller, T., Osborne, G. F., Franklin, S. A., et al. (2014). Dysfunction of the CNS-heart axis in mouse models of Huntington\u2019s disease. PLoS Genetics, 10, e1004550.","journal-title":"PLoS Genetics"},{"key":"9318_CR25","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/thx.34.1.82","volume":"34","author":"PJ Olmesdahl","year":"1979","unstructured":"Olmesdahl, P. J., Gregory, M. A., & Cameron, E. W. (1979). Ultrastructural artefacts in biopsied normal myocardium and their relevance to myocardial biopsy in man. Thorax, 34, 82\u201390.","journal-title":"Thorax"},{"key":"9318_CR26","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/hmg\/6.10.1633","volume":"6","author":"GP Bates","year":"1997","unstructured":"Bates, G. P., Mangiarini, L., Mahal, A., & Davies, S. W. (1997). Transgenic models of Huntington\u2019s disease. Human Molecular Genetics, 6, 1633\u20131637.","journal-title":"Human Molecular Genetics"},{"key":"9318_CR27","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nsmb1215","volume":"14","author":"Y Nagai","year":"2007","unstructured":"Nagai, Y., Inui, T., Popiel, H. A., Fujikake, N., Hasegawa, K., Urade, Y., et al. (2007). A toxic monomeric conformer of the polyglutamine protein. Nature Structural and Molecular Biology, 14, 332\u2013340.","journal-title":"Nature Structural and Molecular Biology"},{"key":"9318_CR28","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1074\/jbc.M110.192013","volume":"286","author":"QC Zhang","year":"2011","unstructured":"Zhang, Q. C., Yeh, T. L., Leyva, A., Frank, L. G., Miller, J., Kim, Y. E., et al. (2011). A compact beta model of huntingtin toxicity. The Journal of Biological Chemistry, 286, 8188\u20138196.","journal-title":"The Journal of Biological Chemistry"},{"key":"9318_CR29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/hmg\/ddm311","volume":"17","author":"T Takahashi","year":"2008","unstructured":"Takahashi, T., Kikuchi, S., Katada, S., Nagai, Y., Nishizawa, M., & Onodera, O. (2008). Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic. Human Molecular Genetics, 17, 345\u2013356.","journal-title":"Human Molecular Genetics"},{"key":"9318_CR30","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1093\/hmg\/ddu151","volume":"23","author":"HY Hsiao","year":"2014","unstructured":"Hsiao, H. Y., Chiu, F. L., Chen, C. M., Wu, Y. R., Chen, H. M., Chen, Y. C., et al. (2014). Inhibition of soluble tumor necrosis factor is therapeutic in Huntington\u2019s disease. Human Molecular Genetics, 23, 4328\u20134344.","journal-title":"Human Molecular Genetics"},{"key":"9318_CR31","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1242\/jcs.050013","volume":"122","author":"S Luo","year":"2009","unstructured":"Luo, S., & Rubinsztein, D. C. (2009). Huntingtin promotes cell survival by preventing Pak2 cleavage. Journal of Cell Science, 122, 875\u2013885.","journal-title":"Journal of Cell Science"},{"key":"9318_CR32","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1038\/sj.emboj.7601445","volume":"25","author":"Y Zhang","year":"2006","unstructured":"Zhang, Y., Leavitt, B. R., van Raamsdonk, J. M., Dragatsis, I., Goldowitz, D., MacDonald, M. E., et al. (2006). Huntingtin inhibits caspase-3 activation. The EMBO Journal, 25, 5896\u20135906.","journal-title":"The EMBO Journal"},{"key":"9318_CR33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/hmg\/ddr475","volume":"21","author":"UP Shirendeb","year":"2012","unstructured":"Shirendeb, U. P., Calkins, M. J., Manczak, M., Anekonda, V., Dufour, B., McBride, J. L., et al. (2012). Mutant huntingtin\u2019s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington\u2019s disease. Human Molecular Genetics, 21, 406\u2013420.","journal-title":"Human Molecular Genetics"},{"key":"9318_CR34","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1093\/hmg\/9.19.2859","volume":"9","author":"SH Li","year":"2000","unstructured":"Li, S. H., Lam, S., Cheng, A. L., & Li, X. J. (2000). Intranuclear huntingtin increases the expression of caspase-1 and induces apoptosis. Human Molecular Genetics, 9, 2859\u20132867.","journal-title":"Human Molecular Genetics"},{"key":"9318_CR35","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00041.2009","volume":"90","author":"C Zuccato","year":"2010","unstructured":"Zuccato, C., Valenza, M., & Cattaneo, E. (2010). Molecular mechanisms and potential therapeutical targets in Huntington\u2019s disease. Physiological Reviews, 90, 905\u2013981.","journal-title":"Physiological Reviews"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-015-9318-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12012-015-9318-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-015-9318-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T03:13:56Z","timestamp":1598843636000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12012-015-9318-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,24]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["9318"],"URL":"https:\/\/doi.org\/10.1007\/s12012-015-9318-y","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,24]]}}}